A Safety and MORAb-028 Dose Determination Study in Subjects With Metastatic Melanoma

Clinical trial NCT01212276 · TERMINATED

Trial details

NCT number: NCT01212276
Sponsor: Morphotek
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Melanoma Malignant Metastatic Melanoma Advanced Melanoma Melanoma

Start date: 2010-12-01
Primary completion: 2012-06-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.